Document ID: chunk:federal_register_of_legislation:F2022C00927:reg:9:p1
Version: federal_register_of_legislation:F2022C00927
Segment Type: reg
Provision Reference: reg 9 (pt 1/3)
Character Range: 5091–8217

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, conjunctivitis or death from conjunctivitis is connected with the circumstances of a person's relevant service:
         (1)          having blepharitis of the affected eye at the time of the clinical onset of conjunctivitis;
         (2)          having an infection of the conjunctiva of the affected eye at the time of the clinical onset of conjunctivitis;
Note: infection of the conjunctiva is defined in the Schedule 1 - Dictionary.
         (3)          having a condition of the affected eye from the specified list of conditions at the time of the clinical onset of conjunctivitis;
Note: specified list of conditions is defined in the Schedule 1 - Dictionary.
         (4)          having a condition that causes chronic lack of sufficient lubrication and moisture on the surface of the affected eye at the time of the clinical onset of conjunctivitis;
            Note: Examples of conditions associated with a chronic lack of sufficient lubrication and moisture on the surface of the eye include dysfunctional tear syndrome, keratoconjunctivitis sicca and Sjögren syndrome.
         (5)          having ocular or periocular exposure to an allergen within the 24 hours before the clinical onset of conjunctivitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
         (5A) having a sensitising exposure to an allergen before the clinical onset of conjunctivitis;
            Note: sensitising exposure to an allergen is defined in the Schedule 1 – Dictionary.
         (6)          having an autoimmune disease at the time of the clinical onset of conjunctivitis;
         (7)          having graft versus host disease at the time of the clinical onset of conjunctivitis;
         (8)          having diabetes mellitus at the time of the clinical onset of conjunctivitis;
         (9)          having topical medication applied to the affected eye within the 48 hours before the clinical onset of conjunctivitis;
         (10)      taking a drug from the specified list of drugs for at least the seven days before the clinical onset of conjunctivitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
         (11)      taking a drug which is associated in the individual with the development of conjunctivitis during drug therapy and either:
            (a)          the improvement of conjunctivitis within seven days of discontinuing or tapering drug therapy; or
            (b)          the redevelopment of conjunctivitis on rechallenge with the same drug;
         where treatment with the drug continued for at least the seven days before the clinical onset of conjunctivitis;
         (12)      having ocular or periocular exposure to an irritant substance within the 24 hours before the clinical onset of conjunctivitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
         (13)      having mustard gas exposure to the affected eye within the 24 hours before the clinical onset of  conjunctivitis;